Skip to main content
. 2018 Jan 3;9(90):36067–36082. doi: 10.18632/oncotarget.23911

Figure 2. The lower MFI of CD80 and CD86 on B10 and CD19+CD24hiCD27hi cells in patients with AP.

Figure 2

Graphs show the cumulative data on the MFI and frequencies of CD80 (A, B) and CD86 (D, E) on CD19+CD24hiCD27hi cells from healthy individuals (n = 21), MAP patients (n = 46) and 17 SAP patients (n = 17). Representative expression of CD80 (C) and CD86 (F) on CD19+CD24hiCD27hi cells from one healthy individual, one MAP patient and one SAP patient are shown. Graphs show the cumulative data on the MFI and frequencies of CD80 (G, J) and CD86 (H, K) on B10 cells from healthy individuals (n = 15), MAP patients (n = 15) and SAP patients (n = 15). Representative expression of CD80 (I) and CD86 (L) on B10 cells from one healthy individual, one MAP patient and one SAP patient are shown.*P < 0.05, **P < 0.01.